Home > Insider Trading > Filing (0001883850-22-000038)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218629	S Leonard Schleifer	777 Old Saw Mill River Road Tarrytown NY 10591	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-04-05	4,461	$710.05	13,831	No	4	S	Indirect	By Trust
Common Stock	Disposition	2022-04-06	2,653	$710.04	11,178	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	465,922	Direct
Common Stock	200,000	Indirect	2021 GRAT
Common Stock	5,874	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,461 shares of Company stock on April 5, 2022 at prices ranging from $710.00 to $710.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2022 at each separate price.
Represents volume-weighted average price of sales of 2,653 shares of Company stock on April 6, 2022 at prices ranging from $710.00 to $710.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 6, 2022 at each separate price.